This phase I study was designed to determine the maximum tolerated dose (MTD) and dose-limiting side effects of combination treatment with paclitaxel (Taxol) and UFT (uracil and tegafur in a 4:1 molar ratio) plus oral
Carsten Oberhoff, MD
Advertisement
Articles by Carsten Oberhoff, MD
Advertisement
Latest Updated Articles
- Paclitaxel and UFT Plus Oral Calcium Folinate in Pretreated Metastatic Breast Cancer
Published: July 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Zanzalintinib Combo Improves Survival in Pretreated Metastatic CRC
3
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
4
Temab-A Displays Early Efficacy in Locally Advanced/Metastatic PDAC
5
